- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CC-96673
Total 834 results
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene Corporation; The Leukemia and Lymphoma SocietyCompleted
-
AmgenCompletedPsoriatic ArthritisSpain, Canada, United States, Australia, Hungary, Poland, Austria, France, New Zealand, South Africa, Russian Federation, Germany, United Kingdom
-
Kaohsiung Veterans General Hospital.Completed
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
AmgenCompletedPsoriatic ArthritisUnited States, Italy, Belgium, France, Canada, Taiwan, United Kingdom, Czechia, Russian Federation, Hungary, Germany, Bulgaria, Estonia, South Africa, Poland, Spain
-
University Health Network, TorontoCompletedCHRONIC POST-TRAUMATIC NEUROPATHIC PAIN IN ANKLE AND FOOTCanada
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRecurrent Chronic Lymphocytic LeukemiaUnited States
-
AmgenCompletedPsoriasis | Plaque-type PsoriasisUnited States, Canada
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
M.D. Anderson Cancer CenterCompletedSolid TumorsUnited States
-
CelgeneNot yet recruitingLymphoma, FollicularUnited States, Australia, Brazil, Canada, Chile, France, Germany, Italy, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Medical College of WisconsinFDA Office of Orphan Products DevelopmentTerminatedHemangiomaUnited States
-
Sonova AGCompletedHearing Loss, Bilateral | Hearing Loss, UnilateralGermany
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
University of California, San FranciscoTerminatedThyroid Gland CarcinomaUnited States
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Acute Bilineal Leukemia | Acute Biphenotypic LeukemiaUnited States
-
CelgeneTerminatedNeoplasms | Lymphoma, Non-HodgkinFrance, Italy, Japan, Spain, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Michaela LiedtkeCelgene CorporationCompletedMultiple MyelomaUnited States
-
AmgenCompletedHealthy SubjectsUnited States
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
GenmabAbbVieRecruitingNon-Hodgkin LymphomaUnited States, France, Israel, Korea, Republic of, Spain, Taiwan, Netherlands, Czechia, Japan, Hungary, Germany, Denmark
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Multilineage Dysplasia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory NeuroblastomaUnited States, Canada
-
Andrei IagaruGeneral ElectricCompletedProstate CancerUnited States
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
CelgeneCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States